Clinical Trials Logo

Filter by:
NCT ID: NCT04487197 Completed - Kidney Transplant Clinical Trials

SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)

Start date: July 15, 2020
Phase:
Study type: Observational

Evaluate SARS-CoV2 infection and the degree of immunity possibly developed in transplanted population using the Luciferase Immuno Precipitation System (LIPS) test.

NCT ID: NCT04485793 Completed - Clinical trials for Hypercholesterolemia

Effect of a Dietary Supplement on Lipid Pattern and Liver Parameters in Hypercholesterolemia

Start date: September 21, 2020
Phase: N/A
Study type: Interventional

The joint ESC/EAS guidelines for the management of dyslipidaemias recommend, for patients at low/moderate CV risk with raised LDL-C, a set of measures collectively defined as "lifestyle interventions", with use of drugs only if the LDL-C levels cannot be controlled with such lifestyle interventions. "Lifestyle interventions" also includes food supplements. The reason is the following: a simple "dietary advice" has been shown (Cochrane review and meta-analysis, Rees et al, 2013) to achieve a modest reduction of total-C and LDL-C. The review reports: Dietary advice reduced total serum cholesterol by 0.15 mmol/L (95% CI 0.06 to 0.23) and LDL cholesterol by 0.16 mmol/L (95% CI 0.08 to 0.24) after 3 to 24 months." An average reduction of LDL-C by 0.16 mmol/L (6.2 mg/dL) is definitely insufficient to control the level of LDL-C in those subjects. Therefore, those subjects would lose motivation to keep dieting. In this context, use of supplements would significantly amplify the result of diet. A significant proportion of ischemic cardiovascular events are believed to be supported by the coexistence of traditional cardiovascular risk factors such as diabetes, hypertension, dyslipidemia, smoking, and others. The aggregation of these factors is accompanied by a significant increase in the risk of cardiovascular events. Observational studies shown the existence of a relationship between cholesterolemia and coronary heart disease, clearly showing that subjects with even modestly increased total cholesterol values over time develop both fatal and non-fatal vascular events with a higher frequency compared to subjects with similar characteristics, but with lower basal values of cholesterol. Numerous controlled intervention studies, on the other hand, have shown that there is a close correlation between cholesterol reduction and cardiovascular risk; in fact, reductions in the plasma concentration of total and LDL-C, obtained through lifestyle modification or specific drugs, result in reductions in the incidence of major coronary events. The effectiveness of these interventions has been demonstrated both in subjects in primary prevention and in patients in secondary prevention.

NCT ID: NCT04485234 Completed - Clinical trials for Coronary Artery Disease

Inclusive Invasive Physiological Assessment in Angina Syndromes Registry

ILIAS Registry
Start date: June 1, 2019
Phase:
Study type: Observational [Patient Registry]

This study evaluates the prognostic value and potential therapeutic impact of combined pressure and flow measurements in the evaluation of epicardial coronary stenosis and microvascular function.

NCT ID: NCT04484883 Completed - Clinical trials for Diabetes Mellitus, Type 2

Performance of Six Equations for Estimating Resting Energy Expenditure in Patients With Type 2 Diabetes

Start date: June 1, 2019
Phase:
Study type: Observational

The present study evaluated the statistical and clinical performance of the six common equations in subjects with type 2 diabetes adopting indirect calorimetry as reference standard

NCT ID: NCT04483856 Completed - Radiodermatitis Clinical Trials

Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis.

DRESDA
Start date: November 2, 2020
Phase: N/A
Study type: Interventional

This is a post marketing, interventional, randomized, single-center, prospective, controlled study, for the evaluation of the clinical performance and tolerability of a cream-based medical device (DermoRelizemaTM cream) in the management care of radiodermatitis in women with breast cancer. Assessments and evaluations will be performed by a physician in a blind fashion. The primary objective is Evaluation of the effects of DermoRelizemaTM cream in the management of the progression of RT-induced skin reactions and toxicity, using the grading system of the Radiation Therapy Oncology Group / European Organization for Research and Treatment of Cancer (RTOG/ EORTC), at the conclusion of the treatment period

NCT ID: NCT04482049 Completed - Clinical trials for Fatty Acid Oxidation Disorder

A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation Disorders

FORWARD
Start date: January 15, 2021
Phase:
Study type: Observational

The purpose of the study is to collect information on disease characteristics from adult patients diagnosed with fatty acid oxidation disorders (FAOD).

NCT ID: NCT04481698 Completed - Thrombosis Clinical Trials

Mesoglycan for Pain Control After Open Excisional HAEMOrrhoidectomy

MeHAEMO
Start date: April 1, 2017
Phase:
Study type: Observational

Haemorrhoidal disease (HD) is the most common proctological disease, with a prevalence that can reach up to 39% of the population. Although I and II degree HD can be treated successfully with medical therapy or office-based procedures , excisional haemorrhoidectomy remains the gold standard technique in patients with III and IV degree HD, obtaining a much lower rate of recurrence than non-excisional methods, such as Doppler-guided haemorrhoidal artery ligation or stapled haemorrhoidopexy. However, both open and closed haemorrhoidectomies are associated with a significant rate of post-operative pain , which may be due to the incorporation of sensitive anal mucosa and fibres of the internal sphincters during the ligation of the vascular pedicle, post-operative scars, hygiene/social habits, hard stool, or oedema of the necessary mucocutaneous bridge. Regarding the oedema/thrombosis of the mucocutaneous bridges, we strongly believe that it is the main cause of post-operative pain, and we have shown that the use of mesoglycan, a polysaccharide complex with antithrombotic and profibrinolytic properties, can reduce the rate of post-operative thrombosis and consequently post-operative pain 7-10 days after the procedures, improving patient quality of life and speeding up the recovery of daily activities. Furthermore, its usefulness is also evident in the treatment of the acute phase of external haemorrhoidal thrombosis. The aim of the study was to evaluate the efficacy of mesoglycan in the post-operative period of patients who underwent open excisional diathermy haemorrhoidectomy, confirming the previously obtained results

NCT ID: NCT04480580 Completed - Covid19 Clinical Trials

Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery

Start date: March 30, 2020
Phase:
Study type: Observational

We have herein analysed the patients admitted to our Department that underwent serologic tests for SARS-CoV-2 either by Ab or RT PCR, to estimate the prevalence of COVID-19 in the setting of a non-dedicated COVID-19 hospital and in a low CoV-2 incidence area, and to evaluate if security measures are necessary for this context.

NCT ID: NCT04479410 Completed - Clinical trials for Electrodes Recognition Ability

Efficient Automated Localization of ECoG Electrodes in CT Images Via Shape Analysis

LOC-ECOG
Start date: August 1, 2020
Phase:
Study type: Observational

People with drug epilepsy (PwE) refractory to anti-seizure medications may be evaluated for surgery. In several cases non invasive presurgical work-up is not sufficient for localization of the Epileptogenic Zone and its correct delineation requires intracranial investigations by means of intraparenchymal or subdural electrodes.The methodological approach with subdural electrodes allows to obtain electrocorticography (ECoG) covering large cortical regions and to map eloquent areas. To delineate the seizure onset zone it is mandatory to precisely localize the electrode position on the cortical surface. Electrodes are usually recognized by processing patients' computed tomography (CT) images using simple image processing (e.g. thresholding) that isolates metal objects. However, also wires, stitches, clips and other metal objects are actually recognized and need to be removed by manual intervention. A new automated method, based on shape analysis, will be retrospectively tested in a group of subjects with refractory focal epilepsy previously investigated with subdural electrodes for diagnostic purposes to provide advanced ECoG subdural electrodes recognition. A total of 24 CT scans with a large number (> 1700) of round platinum electrodes arrays will be recruited for testing.

NCT ID: NCT04477707 Completed - Clinical trials for Diabetic Retinopathy

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)

ReFineDR
Start date: July 23, 2020
Phase:
Study type: Observational

Diabetic retinopathy (DR) is a diabetes complication caused by damage to the small blood vessels inside the retina at the back of the eye. Diabetic retinopathy may cause mild vision problems or eventually blindness. Diabetes is a condition that makes your blood sugar levels higher than they should be. In the early stages of diabetic retinopathy - called non-proliferative diabetic retinopathy (NPDR)- increased blood sugar levels lead to damage to the tiny blood vessels of the retina. This damage results in small outpouchings of the vessel lumens leading to rupture. At the same time the blood vessels can leak and making the retina swell and can cause so called macula edema. In these early stages of DR current treatment to reduce the risk of this eye complication is focused on controlling blood sugar levels and blood pressure. Participants in this study have NPDR, Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD), a condition in which the kidneys become damaged and do not work as they should. These participants are already taking part in one of the phase 3 studies (FIDELIO-DKD and FIGARO-DKD). They study the effect of Finerenone on delaying kidney disease progression and reducing the risk of events that may cause damage to the heart and blood vessels To learn more about the effect of Finerenone on diabetic retinopathy, data from routine eye examinations performed during the two phase 3 studies will be collected and analyzed. All male and female participants included in this study are at least 18 years.